These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 11365763

  • 1. Hepatitis C: new treatment overview.
    Stoia J.
    AIDS Treat News; 1998 Sep 04; (302):5-6. PubMed ID: 11365763
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis C and HIV: ribavirin plus interferon study recruiting.
    AIDS Treat News; 1998 May 15; (No 295):5. PubMed ID: 11365407
    [Abstract] [Full Text] [Related]

  • 3. Ribavirin approved with a big fat price.
    Falkenberg J.
    Notes Undergr; 1998 May 15; (No 37):10-1. PubMed ID: 11365818
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anemia during treatment of hepatitis C in HIV-infected patients.
    Lo Re V, Kostman JR.
    AIDS Read; 2004 Oct 15; 14(10):555-7, 562, 565-71. PubMed ID: 15510392
    [Abstract] [Full Text] [Related]

  • 7. Marketing scam spoils hep C treatment.
    Proj Inf Perspect; 1998 Dec 15; (26):6. PubMed ID: 11366498
    [Abstract] [Full Text] [Related]

  • 8. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R, Planas Vilà R, Durández Lazaro R, Fábregas Puigtió S.
    Gastroenterol Hepatol; 2002 Oct 15; 25(8):483-6. PubMed ID: 12361528
    [Abstract] [Full Text] [Related]

  • 9. Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain.
    Yachimski P, Chung RT.
    AIDS Read; 2004 Oct 15; 14(10):568-9. PubMed ID: 15510393
    [No Abstract] [Full Text] [Related]

  • 10. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT.
    Top HIV Med; 2005 Oct 15; 13(4):112-6. PubMed ID: 16304454
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J.
    Antivir Ther; 2004 Aug 15; 9(4):505-9. PubMed ID: 15456081
    [Abstract] [Full Text] [Related]

  • 12. Opportunistic infections update.
    Proj Inf Perspect; 1998 Dec 15; (26):5-6. PubMed ID: 11366497
    [Abstract] [Full Text] [Related]

  • 13. Consensus statement to Schering-Plough Pharmaceuticals from the health care community regarding Rebetron development and marketing.
    Notes Undergr; 1999 Dec 15; (No 39):9-13. PubMed ID: 11366786
    [Abstract] [Full Text] [Related]

  • 14. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    García-Toro M, Vilella Martorell A, Carral Martínez M, Jimeno Beltrán T, Román Ruiz del Moral Y, Pradas Guerrero C, Gili Planas M, Roca Bennasar M.
    Gastroenterol Hepatol; 2011 Apr 15; 34(4):307-8. PubMed ID: 21376422
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of ribavirin mutagenicity in human hepatitis C virus infection.
    Chevaliez S, Brillet R, Lázaro E, Hézode C, Pawlotsky JM.
    J Virol; 2007 Jul 15; 81(14):7732-41. PubMed ID: 17494069
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ribavirin approved for hepatitis C combination treatment.
    James JS.
    AIDS Treat News; 1998 Jun 19; (No 297):7. PubMed ID: 11365595
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy for hepatitis C.
    TreatmentUpdate; 1998 Mar 19; 10(1):2-3. PubMed ID: 11365430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.